ZCI
NVO

Zevenbergen Capital Investments’s Novo Nordisk NVO Stock Holding History

Zevenbergen Capital Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-32,650
Closed -$679K – 84
2016
Q3 		$679K Buy
32,650
+6,700
+26% +$166K 0.03% 64
2016
Q2 		$698K Buy
25,950
+5,350
+26% +$147K 0.03% 55
2016
Q1 		$558K Buy
20,600
+1,600
+8% +$42.9K 0.03% 57
2015
Q4 		$552K Buy
19,000
+900
+5% +$24.9K 0.02% 53
2015
Q3 		$491K Buy
18,100
+1,000
+6% +$28.3K 0.02% 53
2015
Q2 		$468K Hold
17,100
– – 0.02% 54
2015
Q1 		$456K Buy
17,100
+600
+4% +$13.8K 0.02% 55
2014
Q4 		$349K Buy
16,500
+650
+4% +$14.5K 0.02% 66
2014
Q3 		$377K Sell
15,850
-200
-1% -$4.6K 0.02% 58
2014
Q2 		$371K Sell
16,050
-300
-2% -$6.62K 0.01% 60
2014
Q1 		$373K Buy
16,350
+1,350
+9% +$28.8K 0.01% 64
2013
Q4 		$277K Buy
15,000
+250
+2% +$4.36K 0.01% 64
2013
Q3 		$250K Buy
+14,750
New +$248K 0.01% 62

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Zevenbergen Capital Investments's NVO Position: Q4 2016 in Review

Zevenbergen Capital Investments sold out of Novo Nordisk (NVO) in Q4 2016, closing a stake of 32,650 shares — an estimated $679K sold.

Zevenbergen Capital Investments first reported a position in NVO in Q3 2013 and held it in 13 quarters. The position peaked at $698K in Q2 2016. 483 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Zevenbergen Capital Investments reported no remaining Novo Nordisk position as of Q4 2016 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 32,650 Novo Nordisk shares in Q4 2016, an estimated $679K.
  • Zevenbergen Capital Investments first reported a position in Novo Nordisk in Q3 2013 and held it in 13 quarters.
  • Zevenbergen Capital Investments's Novo Nordisk position peaked at $698K in Q2 2016.
  • 483 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2016, filed 10 Feb 2017.